-
John Griffin
… where he became president in 1993. Griffin received his MBA from Stanford University Graduate School of Business and his BS in finance from the University of Virginia's McIntire School of …
-
Holly S. Andersen, MD
… Morning America and the Early Show. Dr. Andersen graduated from Dartmouth College with a degree in neuroscience. She graduated with honors from the University of Rochester School of Medicine. Dr. …
-
The Michael J. Fox Foundation "Fast Tracks" $4 Million into Broad Range of Parkinson's Research Projects
February 12, 2003
… field of Parkinson’s research. Grant recipients were chosen from a large pool of international applications submitted by scientists from a myriad of disciplines. MJFF awarded scientists from six different countries. One of the review committee’s …
-
New Understandings of the Genetics of Parkinson's Disease Inform Drug Development Today
May 3, 2012
… whose clumping is seen in every case of PD. A clear message from the SAB was the impact MJFF could make in bringing … in genetic analysis and, in the longer term, in moving from genetic discoveries to practical treatments for … latest in how the Foundation is working to bring findings from genetics closer to pharmacy shelves. LRRK2 With …
-
2025 United Airlines NYC Half Marathon Application
… on the waitlist due to capacity constraints. You will hear from us if we are able to welcome you to the team. GENERAL … businesses and organizations, their agents, and employees; from any and all liability, claims, demands, and causes of … in this event and related activities, whether it results from the negligence of any of the above or from any other …
-
Todd Sherer's Testimony at Hearing on NIH and the National Center for Advancing Translational Sciences (NCATS)
March 20, 2012
… I could be most helpful today by sharing some key learnings from our short history. Since our launch in 2000, our … needed at different stages of the process, to move ideas from lab bench to pharmacy shelf. In the first part of the … applied work where scientists home in on discoveries from the “A to F” phase, looking for disease-specific …